A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio
dc.contributor.author | Ucar, Fatih Mehmet | |
dc.date.accessioned | 2024-06-12T11:09:27Z | |
dc.date.available | 2024-06-12T11:09:27Z | |
dc.date.issued | 2016 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Background: Oxidation and inflammation play significant roles in the pathogenesis of coronary artery diseases. Monocyte count to high-density lipoprotein (HDL) cholesterol ratio (MHR) is a new marker and has revealed as an indicator of inflammation in the literature. The present study aimed to search the effect of MHR on in-stent restenosis (ISR) in patients with stable or unstable angina pectoris undergoing bare-metal stent (BMS) implantation. Methods: A total of 468 consecutive stable or unstable angina pectoris patients (mean age 60.3 +/- 10.1 and 70 % men) who had undergone successful BMS implantation were included the study. Serum samples were obtained before the procedure. Results: The mean period between two coronary angiography procedures was 14 +/- 7.9 months. The baseline MHR levels were significantly higher in patients that had ISR (odds ratio, 3.64; 95 % confidence interval, 2.45-4.84; P < 0. 001). Stent diameter, the time between the two coronary angiographic studies, uric acid and MHR levels emerged as independent predictors of ISR. Conclusions: Our results indicate that elevated MHR is an independent and powerful predictor of ISR in patients with stable or unstable angina pectoris who underwent successful BMS implantation. | en_US |
dc.identifier.doi | 10.1186/s12872-016-0367-3 | |
dc.identifier.issn | 1471-2261 | |
dc.identifier.pmid | 27716070 | en_US |
dc.identifier.scopus | 2-s2.0-84989311505 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.1186/s12872-016-0367-3 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/22793 | |
dc.identifier.volume | 16 | en_US |
dc.identifier.wos | WOS:000385774400001 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Biomed Central Ltd | en_US |
dc.relation.ispartof | Bmc Cardiovascular Disorders | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Novel Marker | en_US |
dc.subject | Monocyte /HDL Cholesterol Ratio | en_US |
dc.subject | Instent Restenosis | en_US |
dc.subject | Bare Metal | en_US |
dc.subject | Percutaneous Coronary Intervention | en_US |
dc.subject | Density-Lipoprotein | en_US |
dc.subject | Intimal Hyperplasia | en_US |
dc.subject | Artery-Disease | en_US |
dc.subject | Heart-Disease | en_US |
dc.subject | Inflammation | en_US |
dc.subject | Angioplasty | en_US |
dc.subject | Thrombosis | en_US |
dc.subject | Era | en_US |
dc.title | A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio | en_US |
dc.type | Article | en_US |